PN
Last reporting period 30 Sep, 2023
Updated —
Last price
—
Market cap $B
1.332
Exchange
XNAS - Nasdaq
0.42 B
Last period Equity ,USD
221%
Equity has increased in 3 years
What is Equity ?
Equity is the amount of money that the company would receive if all its assets were sold and all debt obligations were paid off.
See also POINT Biopharma
Company Analysis
PNT valuation, rating, competitors, insights and company profile
Eyestock Rating
PNT financial analysis by Eyestock methodology
Valuation
PNT valuation using historical relative method
Statements
PNT Income Statements, Balance Sheet and Cash Flow Statements
Dividends
PNT dividend yield and annual dividend
Equity is the amount of money that the company would receive if all its assets were sold and all debt obligations were paid off.
POINT Biopharma`s Equity for the period ended 2023-09-30 is 0.42 B USD
